These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7492443)

  • 1. Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection.
    Montefiori DC; Reimann KA; Letvin NL; Zhou J; Hu SL
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):963-70. PubMed ID: 7492443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys.
    Montefiori DC; Baba TW; Li A; Bilska M; Ruprecht RM
    J Immunol; 1996 Dec; 157(12):5528-35. PubMed ID: 8955203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.
    Montefiori DC; Robinson WE; Hirsch VM; Modliszewski A; Mitchell WM; Johnson PR
    J Virol; 1990 Jan; 64(1):113-9. PubMed ID: 2152808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.
    Schlienger K; Montefiori DC; Mancini M; Rivière Y; Tiollais P; Michel ML
    J Virol; 1994 Oct; 68(10):6578-88. PubMed ID: 7521918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.
    Haigwood NL; Misher L; Chin SM; Blair M; Planelles V; Scandella CJ; Steimer KS; Gardner MB; Yilma T; Hirsch VM
    J Med Primatol; 1992; 21(2-3):82-90. PubMed ID: 1433271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent enhancement and neutralization pattern of sera from SIV-infected or HIV-2-vaccinated rhesus monkeys.
    Le Grand R; Vogt G; Chapel A; Dormont D
    J Med Primatol; 1991 Jun; 20(4):172-6. PubMed ID: 1942007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent enhancement of SIV infection: further characterization and cross reactivity between macaque and sooty mangabey isolates.
    Montefiori DC; Robinson WE; Hirsch VM; Modliszewski A; Mitchell WM; Johnson PR
    J Med Primatol; 1990; 19(3-4):269-78. PubMed ID: 2231684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
    Pinczewski J; Zhao J; Malkevitch N; Patterson LJ; Aldrich K; Alvord WG; Robert-Guroff M
    Viral Immunol; 2005; 18(1):236-43. PubMed ID: 15802969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.
    Hu SL; Stallard V; Abrams K; Barber GN; Kuller L; Langlois AJ; Morton WR; Benveniste RE
    J Med Primatol; 1993; 22(2-3):92-9. PubMed ID: 8411113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-infection immunodeficiency virus control by neutralizing antibodies.
    Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    PLoS One; 2007 Jun; 2(6):e540. PubMed ID: 17579714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
    Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection.
    Lewis MG; Elkins WR; McCutchan FE; Benveniste RE; Lai CY; Montefiori DC; Burke DS; Eddy GA; Shafferman A
    Vaccine; 1993 Oct; 11(13):1347-55. PubMed ID: 7507625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel application of nonhuman primate tethering system for evaluation of acute phase SIVmac251 infection in rhesus macaques (Macaca mulatta).
    Keckler MS; Hodara VL; Parodi LM; Giavedoni LD
    Viral Immunol; 2007 Dec; 20(4):623-34. PubMed ID: 18158735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
    Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.